A Multicenter Randomized Double-blind 2-Part Phase 2 Study to Evaluate the Efficacy and Safety of GS-1427 in Adult Participants With Moderately to Severely Active Ulcerative Colitis (UC)

Brief description of study

The purpose of this study is to learn more about the study drug, GS-1427. This will include:

Testing if 3 different doses of GS-1427 work to treat moderate to severe Ulcerative Colitis (UC)
Testing if GS-1427 is safe for people with UC
Testing how the body processes and responds to GS-1427

Clinical Study Identifier: s24-00136

ClinicalTrials.gov Identifier: NCT06290934

Principal Investigator: Jordan E Axelrad.

Other Investigators: Elie S Al Kazzi, Shannon Chang, Adam Faye, Simon J Hong, Ariela Holmer, David P Hudesman.

Contact the research team to learn more about this study.

Your Email

Not a valid e-mail address

Please Provide Email Address

First Name

First name is mandatory

Last Name

Your Phone

Please provide phone number

Invalid phone number

Valid phone number

Comments

Send Confirmation of This To Me

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Clinical Research Studies